Molecule Details
| InChIKey | XTDMSJJFEQHMRK-UHFFFAOYSA-N |
|---|---|
| Compound Name | Ethyl 5-({[(5-benzyl-1,3,4-oxadiazol-2-yl)thio]acetyl}amino)-4-cyano-3-methyl-2-thiophenecarboxylate |
| Canonical SMILES | CCOC(=O)c1sc(NC(=O)CSc2nnc(Cc3ccccc3)o2)c(C#N)c1C |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 4 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 6.74 |
| Source | BindingDB |
2D Structure
Activity Profile
Target Activities (4)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| P49795 | RGS19 | Homo sapiens | Human | PF00615 | 6.8 | Ki | BindingDB |
| P57771 | RGS8 | Homo sapiens | Human | PF00615 | 6.8 | Ki | BindingDB |
| O15492 | RGS16 | Homo sapiens | Human | PF00615 | 6.2 | Ki | BindingDB |
| P04585 | gag-pol | Human immunodeficiency virus type 1 group M subtype B (isolate HXB2) | Pathogen | PF00540 PF19317 PF00552 PF02022 PF00075 PF00665 PF00077 PF00078 PF06815 PF06817 PF00098 | 7.0 | IC50 | BindingDB |